Terms: = Brain cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Treatment
501 results:
1. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Sabine Roth K; Weindler JJ
Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
[TBL] [Abstract] [Full Text] [Related]
2. Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to cancer Care.
Court LE; Aggarwal A; Jhingran A; Naidoo K; Netherton T; Olanrewaju A; Peterson C; Parkes J; Simonds H; Trauernicht C; Zhang L; Beadle BM;
JCO Glob Oncol; 2024 Mar; 10():e2300376. PubMed ID: 38484191
[TBL] [Abstract] [Full Text] [Related]
3. Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases.
Abdelmessih E; Ahuja T; Wo S; Sango A; Papadopoulos J; Green D; Xiang E
J Thromb Thrombolysis; 2024 Mar; 57(3):418-427. PubMed ID: 38281232
[TBL] [Abstract] [Full Text] [Related]
4. Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma.
Khodair AI; El-Hallouty SM; Cagle-White B; Abdel Aziz MH; Hanafy MK; Mowafy S; Hamdy NM; Kassab SE
Eur J Med Chem; 2024 Feb; 265():116049. PubMed ID: 38185054
[TBL] [Abstract] [Full Text] [Related]
5. Cardiac structure, function, and coronary anatomy 10 years after isolated contemporary adjuvant radiotherapy in breast cancer patients with low cardiovascular baseline risk.
Krug P; Geets X; Berlière M; Duhoux F; Beauloye C; Pasquet A; Vancraeynest D; Pouleur AC; Gerber BL
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):645-656. PubMed ID: 38128112
[TBL] [Abstract] [Full Text] [Related]
6. The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report.
Findlay MC; Sabahi M; Azab M; Drexler R; Rotermund R; Ricklefs FL; Flitsch J; Smith TR; Kilgallon JL; Honegger J; Nasi-Kordhishti I; Gardner PA; Gersey ZC; Abdallah HM; Jane JA; Knappe UJ; Uksul N; Schroder HWS; Eördögh M; Losa M; Mortini P; Gerlach R; Antunes ACM; Couldwell WT; Budohoski KP; Rennert RC; Karsy M
Clin Neurol Neurosurg; 2024 Jan; 236():108079. PubMed ID: 38091700
[TBL] [Abstract] [Full Text] [Related]
7. In vitro and in vivo pharmacokinetics, disposition, and drug-drug interaction potential of tinengotinib (TT-00420), a promising investigational drug for treatment of cholangiocarcinoma and other solid tumors.
Ni S; Li L; Sun X; Wang Y; Yu Q; Wang W; Gu Z; Yu Z; Wu D; Wu F; Jiang S; Peng P
Eur J Pharm Sci; 2024 Jan; 192():106658. PubMed ID: 38048851
[TBL] [Abstract] [Full Text] [Related]
8. Internal circadian misallignment in a mouse model of chemotherapy induced fatigue.
Wang Y; van Beurden AW; Tersteeg MMH; Michel S; Kastelein A; Neefjes J; Rohling JHT; Meijer JH; Deboer T
Brain Behav Immun; 2024 Jan; 115():588-599. PubMed ID: 37984623
[TBL] [Abstract] [Full Text] [Related]
9. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Kilburn LB; Khuong-Quang DA; Hansford JR; Landi D; van der Lugt J; Leary SES; Driever PH; Bailey S; Perreault S; McCowage G; Waanders AJ; Ziegler DS; Witt O; Baxter PA; Kang HJ; Hassall TE; Han JW; Hargrave D; Franson AT; Yalon Oren M; Toledano H; Larouche V; Kline C; Abdelbaki MS; Jabado N; Gottardo NG; Gerber NU; Whipple NS; Segal D; Chi SN; Oren L; Tan EEK; Mueller S; Cornelio I; McLeod L; Zhao X; Walter A; Da Costa D; Manley P; Blackman SC; Packer RJ; Nysom K
Nat Med; 2024 Jan; 30(1):207-217. PubMed ID: 37978284
[TBL] [Abstract] [Full Text] [Related]
10. NRF1 Alleviated Oxidative Stress of Glioblastoma Cells by Regulating nor1.
Wang J; Chen S; Xiang W; Zhu Q; Ren N
Folia Biol (Praha); 2023; 69(1):13-21. PubMed ID: 37962027
[TBL] [Abstract] [Full Text] [Related]
11. Framework for Radiation Oncology Department-wide Evaluation and Implementation of Commercial Artificial Intelligence Autocontouring.
Maes D; Gates EDH; Meyer J; Kang J; Nguyen BT; Lavilla M; Melancon D; Weg ES; Tseng YD; Lim A; Bowen SR
Pract Radiat Oncol; 2024; 14(2):e150-e158. PubMed ID: 37935308
[TBL] [Abstract] [Full Text] [Related]
12. Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial.
McMullan C; Retzer A; Hughes SE; Aiyegbusi OL; Bathurst C; Boyd A; Coleman J; Davies EH; Denniston AK; Dunster H; Frost C; Harding R; Hunn A; Kyte D; Malpass R; McNamara G; Mitchell S; Mittal S; Newsome PN; Price G; Rowe A; van Reil W; Walker A; Wilson R; Calvert M
J Patient Rep Outcomes; 2023 Oct; 7(1):98. PubMed ID: 37812323
[TBL] [Abstract] [Full Text] [Related]
13. Primary brain tumours in adults.
van den Bent MJ; Geurts M; French PJ; Smits M; Capper D; Bromberg JEC; Chang SM
Lancet; 2023 Oct; 402(10412):1564-1579. PubMed ID: 37738997
[TBL] [Abstract] [Full Text] [Related]
14. Adamantinomatous craniopharyngioma: evolution in the management.
Massimi L; Palombi D; Musarra A; Bianchi F; Frassanito P; Tamburrini G; Di Rocco C
Childs Nerv Syst; 2023 Oct; 39(10):2613-2632. PubMed ID: 37728836
[TBL] [Abstract] [Full Text] [Related]
15. Frequency of social burden and underage children in neuro-oncological patients.
Kamp MA; von Sass C; Januzi D; Dibué M; Libourius K; Lawson McLean AC; Baumgarten P; Lawson McLean A; Dinc N; Senft CA
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15911-15922. PubMed ID: 37679652
[TBL] [Abstract] [Full Text] [Related]
16. Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature.
Kang Y; Zhen H; Ma N; Zhao H; Cao B
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16239-16246. PubMed ID: 37676267
[TBL] [Abstract] [Full Text] [Related]
17. The treatment of aggressive prolactinomas with everolimus.
Lin AL; Geer EB; Lala N; Page-Wilson G; Magge R; Young RJ; Tabar V
Pituitary; 2023 Aug; 26(4):474-481. PubMed ID: 37428396
[TBL] [Abstract] [Full Text] [Related]
18. Ketonization of Ginsenoside C-K by Novel Recombinant 3-β-Hydroxysteroid Dehydrogenases and Effect on Human Fibroblast Cells.
Jin Y; Wang D; Im WT; Siddiqi MZ; Yang DC
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175202
[TBL] [Abstract] [Full Text] [Related]
19. treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research Network.
Dewan MC; Isaacs AM; Cools MJ; Yengo-Kahn A; Naftel RP; Jensen H; Reeder RW; Holubkov R; Haizel-Cobbina J; Riva-Cambrin J; Jafrani RJ; Pindrik JA; Jackson EM; Judy BF; Kurudza E; Pollack IF; Mcdowell MM; Hankinson TC; Staulcup S; Hauptman J; Hall K; Tamber MS; Cheong A; Warsi NM; Rocque BG; Saccomano BW; Snyder RI; Kulkarni AV; Kestle JRW; Wellons JC;
J Neurooncol; 2023 May; 163(1):123-132. PubMed ID: 37129738
[TBL] [Abstract] [Full Text] [Related]
20. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors.
Brown AL; Sok P; Raghubar KP; Lupo PJ; Richard MA; Morrison AC; Yang JJ; Stewart CF; Okcu MF; Chintagumpala MM; Gajjar A; Kahalley LS; Conklin H; Scheurer ME
Neuro Oncol; 2023 Sep; 25(9):1698-1708. PubMed ID: 37038335
[TBL] [Abstract] [Full Text] [Related]
[Next]
